Gordon B. Jr. Cutler
#122,849
Most Influential Person Now
Gordon B. Jr. Cutler's AcademicInfluence.com Rankings
Gordon B. Jr. Cutlermedical Degrees
Medical
#1903
World Rank
#2286
Historical Rank
Public Health
#260
World Rank
#269
Historical Rank
Gordon B. Jr. Cutlerphilosophy Degrees
Philosophy
#5618
World Rank
#8472
Historical Rank
Logic
#2860
World Rank
#3925
Historical Rank
Download Badge
Medical Philosophy
Gordon B. Jr. Cutler's Degrees
- Bachelors Biology Stanford University
- Doctorate Medicine Harvard University
Similar Degrees You Can Earn
Why Is Gordon B. Jr. Cutler Influential?
(Suggest an Edit or Addition)Gordon B. Jr. Cutler's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Designing Randomized, Controlled Trials Aimed at Preventing or Delaying Functional Decline and Disability in Frail, Older Persons: A Consensus Report (2004) (1004)
- Neuroendocrine Tumors of the Lung With Proposed Criteria for Large‐Cell Neuroendocrine Carcinoma: An Ultrastructural, Immunohistochemical, and Flow Cytometric Study of 35 Cases (1991) (841)
- Petrosal sinus sampling with and without corticotropin-releasing hormone for the differential diagnosis of Cushing's syndrome. (1991) (778)
- A constitutively activating mutation of the luteinizing hormone receptor in familial male precocious puberty (1993) (707)
- Patterns of human growth. (1995) (434)
- Cushing's syndrome in children and adolescents. Presentation, diagnosis, and therapy. (1994) (381)
- Estrogen levels in childhood determined by an ultrasensitive recombinant cell bioassay. (1994) (372)
- Hormones, emotional dispositions, and aggressive attributes in young adolescents. (1987) (353)
- The effect of anorexia nervosa and refeeding on growth hormone-binding protein, the insulin-like growth factors (IGFs), and the IGF-binding proteins. (1992) (343)
- Adrenarche: a survey of rodents, domestic animals, and primates. (1978) (329)
- The corticotropin-releasing factor stimulation test. An aid in the evaluation of patients with Cushing's syndrome. (1984) (318)
- Successful treatment of Cushing's syndrome with the glucocorticoid antagonist RU 486. (1985) (313)
- The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. (1994) (280)
- Corticotropin-releasing hormone stimulation following low-dose dexamethasone administration. A new test to distinguish Cushing's syndrome from pseudo-Cushing's states. (1993) (277)
- Preoperative lateralization of ACTH-secreting pituitary microadenomas by bilateral and simultaneous inferior petrosal venous sinus sampling. (1985) (275)
- Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone-(1-34) versus calcitriol and calcium. (2003) (271)
- Therapeutic use of pituitary desensitization with a long-acting lhrh agonist: a potential new treatment for idiopathic precocious puberty. (1981) (263)
- The advantage of measuring stimulated as compared with spontaneous growth hormone levels in the diagnosis of growth hormone deficiency. (1988) (255)
- Genetic heterogeneity of constitutively activating mutations of the human luteinizing hormone receptor in familial male-limited precocious puberty. (1995) (233)
- Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism. (2012) (225)
- Gonadotropin secretory dynamics during puberty in normal girls and boys. (1990) (224)
- The role of estrogen in bone growth and maturation during childhood and adolescence (1997) (223)
- Migratory arrest of gonadotropin-releasing hormone neurons in transgenic mice. (1991) (219)
- Effect of growth hormone treatment on adult height in peripubertal children with idiopathic short stature: a randomized, double-blind, placebo-controlled trial. (2004) (217)
- Short-term treatment of idiopathic precocious puberty with a long-acting analogue of luteinizing hormone-releasing hormone. A preliminary report. (1981) (217)
- A simplified morning ovine corticotropin-releasing hormone stimulation test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. (1993) (216)
- Molecular genetics and pathophysiology of 17 beta-hydroxysteroid dehydrogenase 3 deficiency. (1996) (210)
- A preliminary study of the effect of estrogen dose on growth in Turner's syndrome. (1983) (200)
- Human corticotropin-releasing factor in man: pharmacokinetic properties and dose-response of plasma adrenocorticotropin and cortisol secretion. (1984) (198)
- Mutations in the Ca(2+)-sensing receptor gene cause autosomal dominant and sporadic hypoparathyroidism. (1996) (197)
- Repeat transsphenoidal surgery for Cushing's disease. (1989) (190)
- Increased final height in precocious puberty after long-term treatment with LHRH agonists: the National Institutes of Health experience. (2001) (190)
- Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism. (1996) (188)
- Early repeat surgery for persistent Cushing's disease. (1994) (180)
- The NIH experience with precocious puberty: diagnostic subgroups and response to short-term luteinizing hormone releasing hormone analogue therapy. (1986) (179)
- Premature thelarche and central precocious puberty: the relationship between clinical presentation and the gonadotropin response to luteinizing hormone-releasing hormone. (1988) (177)
- Glucocorticoid hormone resistance during primate evolution: receptor-mediated mechanisms. (1982) (175)
- The ovine corticotropin-releasing hormone stimulation test and the dexamethasone suppression test in the differential diagnosis of Cushing's syndrome. (1986) (174)
- Critical evaluation of the safety of recombinant human growth hormone administration: statement from the Growth Hormone Research Society. (2001) (171)
- Flutamide, testolactone, and reduced hydrocortisone dose maintain normal growth velocity and bone maturation despite elevated androgen levels in children with congenital adrenal hyperplasia. (2000) (167)
- Urine free cortisol in the high-dose dexamethasone suppression test for the differential diagnosis of the Cushing syndrome. (1992) (161)
- A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism. (1998) (160)
- Gadolinium DTPA enhanced MR imaging of ACTH-secreting microadenomas of the pituitary gland. (1988) (157)
- Growth hormone secretory dynamics in Turner syndrome. (1985) (156)
- Growth hormone (GH) treatment to final height in children with idiopathic short stature: evidence for a dose effect. (2005) (154)
- Pituitary adenomas in patients with Cushing disease: initial experience with Gd-DTPA-enhanced MR imaging. (1987) (152)
- Long-term treatment of 12 children with chronic hypoparathyroidism: a randomized trial comparing synthetic human parathyroid hormone 1-34 versus calcitriol and calcium. (2010) (151)
- Ectopic adrenocorticotropic hormone syndrome: localization studies in 28 patients. (1989) (150)
- Spontaneous growth hormone secretion increases during puberty in normal girls and boys (1991) (150)
- A comparison of the standard high dose dexamethasone suppression test and the overnight 8-mg dexamethasone suppression test for the differential diagnosis of adrenocorticotropin-dependent Cushing's syndrome. (1994) (149)
- Steroid transport, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells (1996) (149)
- A single midnight serum cortisol measurement distinguishes Cushing's syndrome from pseudo-Cushing states. (1998) (144)
- Effects of estrogen on nonverbal processing speed and motor function in girls with Turner's syndrome. (1998) (142)
- Catch-up growth after glucocorticoid excess: a mechanism intrinsic to the growth plate. (1994) (141)
- Treatment with a luteinizing hormone-releasing hormone agonist in adolescents with short stature. (2003) (140)
- Developmental processes in early adolescence: relationships between adolescent adjustment problems and chronologic age, pubertal stage, and puberty-related serum hormone levels. (1987) (137)
- Late-onset 21-hydroxylase deficiency mimicking idiopathic hirsutism or polycystic ovarian disease. (1982) (134)
- A nonsense mutation of the human luteinizing hormone receptor gene in Leydig cell hypoplasia. (1995) (130)
- Glucocorticoid action and the clinical features of Cushing's syndrome. (1994) (127)
- Effects of once versus twice-daily parathyroid hormone 1-34 therapy in children with hypoparathyroidism. (2008) (127)
- Normal bone density of the wrist and spine and increased wrist fractures in girls with Turner's syndrome. (1991) (126)
- Compound heterozygous mutations of the luteinizing hormone receptor gene in Leydig cell hypoplasia. (1996) (125)
- Psychological adaptation in children with idiopathic short stature treated with growth hormone or placebo. (2004) (125)
- Hypogonadotropic hypogonadism in a female caused by an X-linked recessive mutation in the DAX1 gene. (1999) (123)
- Use of estrogen in young girls with Turner syndrome (2000) (123)
- The developmental changes in plasma adrenal androgens during infancy and adrenarche are associated with changing activities of adrenal microsomal 17-hydroxylase and 17,20-desmolase. (1981) (118)
- The corticotropin-releasing hormone test in the postoperative evaluation of patients with cushing's syndrome. (1987) (115)
- Isolation and characterization of the human gonadotropin-releasing hormone gene in the hypothalamus and placenta. (1990) (115)
- Reproductive axis after discontinuation of gonadotropin-releasing hormone analog treatment of girls with precocious puberty: long term follow-up comparing girls with hypothalamic hamartoma to those with idiopathic precocious puberty. (1999) (114)
- Adult height in precocious puberty after long-term treatment with deslorelin. (1991) (111)
- A Single Midnight Serum Cortisol Measurement Distinguishes Cushing’s Syndrome from Pseudo-Cushing States (1998) (111)
- High fluid intake increases urine free cortisol excretion in normal subjects. (1998) (110)
- Evidence for direct estrogen regulation of the human gonadotropin-releasing hormone gene. (1991) (110)
- Treatment of familial male precocious puberty with spironolactone and testolactone. (1989) (108)
- Relations between Hormone Levels and Observational Measures of Aggressive Behavior of Young Adolescents in Family Interactions. (1988) (108)
- The corticotropin-releasing hormone stimulation test: a possible aid in the evaluation of patients with adrenal insufficiency. (1984) (107)
- The relation of relative hormonal levels and physical development and social-emotional behavior in young adolescents (1985) (105)
- Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects. (1985) (105)
- Cushing syndrome due to primary pigmented nodular adrenocortical disease: findings at CT and MR imaging. (1989) (103)
- Continuous administration of synthetic ovine corticotropin-releasing factor in man. Physiological and pathophysiological implications. (1985) (103)
- The dexamethasone-suppressed corticotropin-releasing hormone stimulation test differentiates mild Cushing's disease from normal physiology. (1998) (102)
- Lipid abnormalities in Turner syndrome. (1995) (102)
- Growth hormone plus childhood low-dose estrogen in Turner's syndrome. (2011) (102)
- Dexamethasone acts locally to inhibit longitudinal bone growth in rabbits. (1992) (101)
- Developmental processes in early adolescence. Relations among chronologic age, pubertal stage, height, weight, and serum levels of gonadotropins, sex steroids, and adrenal androgens. (1987) (100)
- Testicular adrenal rest tissue in congenital adrenal hyperplasia: findings at Gray-scale and color Doppler US. (1996) (99)
- Short term, low dose estradiol accelerates ulnar growth in boys. (1985) (99)
- The use of adrenalectomy as a treatment for congenital adrenal hyperplasia. (1996) (98)
- Safety of growth hormone treatment in pediatric patients with idiopathic short stature. (2005) (97)
- Macronodular adrenal hyperplasia in Cushing disease. (1988) (93)
- Near final height in pubertal growth hormone (GH)-deficient patients treated with GH alone or in combination with luteinizing hormone-releasing hormone analog: results of a prospective, randomized trial. (2000) (92)
- Behavior problems and social competence in girls with true precocious puberty. (1985) (91)
- Developmental changes in neuroendocrine regulation of gonadotropin secretion in gonadal dysgenesis. (1983) (89)
- Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. (1988) (89)
- Effect of low doses of estradiol on 6-month growth rates and predicted height in patients with Turner syndrome. (1986) (88)
- Testicular adrenal rest tissue in congenital adrenal hyperplasia: serial sonographic and clinical findings. (1999) (87)
- Management of the ectopic ACTH syndrome due to thoracic carcinoids. (1990) (87)
- Induction of growth plate cartilage ossification by basic fibroblast growth factor. (1994) (86)
- Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism. (2014) (86)
- Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndrome. (1990) (85)
- Treatment of precocious puberty in the McCune-Albright syndrome with the aromatase inhibitor testolactone. (1986) (85)
- Dissociation of cortisol and adrenal androgen secretion in patients with secondary adrenal insufficiency. (1979) (84)
- The limited ability of inferior petrosal sinus sampling with corticotropin-releasing hormone to distinguish Cushing's disease from pseudo-Cushing states or normal physiology. (1993) (84)
- Therapeutic controversy: The role of laparoscopic surgery in adrenal disease. (1998) (83)
- Dexamethasone increases growth hormone receptor messenger ribonucleic acid levels in liver and growth plate. (1994) (82)
- A new constitutively activating point mutation in the luteinizing hormone/choriogonadotropin receptor gene in cases of male-limited precocious puberty. (1995) (82)
- Self-concept and behavior in adolescent girls with Turner syndrome: potential estrogen effects. (1996) (82)
- Detection of ACTH-producing bronchial carcinoid tumors: MR imaging vs CT. (1991) (81)
- GH treatment to final height produces similar height gains in patients with SHOX deficiency and Turner syndrome: results of a multicenter trial. (2013) (80)
- The relationship of saline-induced changes in vasopressin secretion to basal and corticotropin-releasing hormone-stimulated adrenocorticotropin and cortisol secretion in man. (1987) (79)
- Novel CYP11B1 mutations in congenital adrenal hyperplasia due to steroid 11 beta-hydroxylase deficiency. (1998) (79)
- Six-year results of spironolactone and testolactone treatment of familial male-limited precocious puberty with addition of deslorelin after central puberty onset. (1999) (79)
- Long-term testolactone therapy for precocious puberty in girls with the McCune-Albright syndrome. (1993) (77)
- Ullrich-Turner syndrome: neurodevelopmental changes from childhood through adolescence. (1995) (77)
- Corticotropin-releasing factor: pharmacokinetics in man. (1984) (75)
- The effects of corticotropin releasing factor on the anterior pituitary function of stalk-sectioned cynomolgus macaques: dose response of cortisol secretion. (1982) (75)
- Factitious Cushing syndrome. (1996) (74)
- Absence of pubertal gonadotropin secretion in girls with McCune-Albright syndrome. (1984) (72)
- Prospective Safety Surveillance of GH-Deficient Adults: Comparison of GH-Treated vs Untreated Patients (2013) (71)
- Time to recovery of the hypothalamic-pituitary-adrenal axis after curative resection of adrenal tumors in patients with Cushing's syndrome. (1990) (70)
- Inferior petrosal sinus sampling in healthy subjects reveals a unilateral corticotropin-releasing hormone-induced arginine vasopressin release associated with ipsilateral adrenocorticotropin secretion. (1996) (70)
- The Metyrapone and Dexamethasone Suppression Tests for the Differential Diagnosis of the Adrenocorticotropin-Dependent Cushing Syndrome: A Comparison (1994) (70)
- The ovine corticotropin-releasing hormone (CRH) stimulation test is superior to the human CRH stimulation test for the diagnosis of Cushing's disease. (1989) (69)
- A preliminary study of flutamide, testolactone, and reduced hydrocortisone dose in the treatment of congenital adrenal hyperplasia. (1996) (67)
- The phenotype of short stature homeobox gene (SHOX) deficiency in childhood: contrasting children with Leri-Weill dyschondrosteosis and Turner syndrome. (2005) (67)
- Prevalence and incidence of diabetes mellitus in GH-treated children and adolescents: analysis from the GeNeSIS observational research program. (2011) (67)
- A sporadic case of male-limited precocious puberty has the same constitutively activating point mutation in luteinizing hormone/choriogonadotropin receptor gene as familial cases. (1994) (67)
- Mifepristone: treatment of Cushing's syndrome. (1996) (66)
- Ovine corticotropin-releasing factor administration in normal men. Pituitary and adrenal responses in the morning and evening. (1985) (65)
- Pulsatile administration of human corticotropin-releasing hormone in patients with secondary adrenal insufficiency: restoration of the normal cortisol secretory pattern. (1986) (64)
- Andrenarche and its relationship to the onset of puberty. (1980) (63)
- Androgen-responsive aspects of cognition in girls with Turner syndrome. (2003) (62)
- Use of aromatase inhibitors in precocious puberty. (1999) (62)
- Inactivation of the luteinizing hormone/chorionic gonadotropin receptor by an insertional mutation in Leydig cell hypoplasia. (1998) (61)
- Adrenocorticotropic hormone--secreting islet cell tumors: are they always malignant? (1994) (61)
- Selective venous sampling from the cavernous sinuses is not a more reliable technique than sampling from the inferior petrosal sinuses in Cushing's syndrome. (1995) (60)
- A case of male-limited precocious puberty caused by a point mutation in the second transmembrane domain of the luteinizing hormone choriogonadotropin receptor gene. (1996) (59)
- Cushing syndrome: pituitary CT scanning. (1987) (59)
- Absence of growth hormone effects on cognitive function in girls with Turner syndrome. (1997) (58)
- Daily rhythm of plasma melatonin in normal and precocious puberty. (1982) (58)
- CT of cerebral abnormalities in precocious puberty. (1987) (58)
- Steroid treatment, accumulation, and antagonism of P-glycoprotein in multidrug-resistant cells. (1996) (58)
- Determinants of growth during gonadotropin-releasing hormone analog therapy for precocious puberty. (2004) (57)
- Identification of two separate allelic mutations in the lipoprotein lipase gene of a patient with the familial hyperchylomicronemia syndrome. (1991) (57)
- Treatment of familial male precocious puberty with spironolactone, testolactone, and deslorelin. (1993) (57)
- CT and MR imaging of massive macronodular adrenocortical disease: a rare cause of autonomous primary adrenal hypercortisolism. (1991) (57)
- Adrenocorticotropin-stimulated adrenal androgen secretion in anorexia nervosa: impaired secretion at low weight with normalization after long-term weight recovery. (1985) (57)
- Six-year results of luteinizing hormone releasing hormone (LHRH) agonist treatment in children with LHRH-dependent precocious puberty. (1989) (57)
- Dissociation of adrenarche and gonadarche in precocious puberty and in isolated hypogonadotropic hypogonadism. (1987) (56)
- Ocular findings in Turner syndrome. A prospective study. (1984) (56)
- Estrogen receptor in rat adrenal gland. (1978) (56)
- Luteinizing hormone-releasing hormone analog treatment of boys with hypothalamic hamartoma and true precocious puberty. (1984) (54)
- Usefulness of inferior petrosal sinus venous endocrine markers in Cushing's disease. (1988) (54)
- Effective reversibility of the signs and symptoms of hypercortisolism by bilateral adrenalectomy. (1993) (53)
- Low growth hormone levels are related to increased body mass index and do not reflect impaired growth in luteinizing hormone-releasing hormone agonist-treated children with precocious puberty. (1991) (53)
- The effects of sex steroids on ulnar growth during adolescence. (1984) (52)
- New ideas for medical treatment of congenital adrenal hyperplasia. (2001) (51)
- Petrosal sinus sampling: discordant lateralization of ACTH-secreting pituitary microadenomas before and after stimulation with corticotropin-releasing hormone. (1990) (51)
- Use of ultrasensitive recombinant cell bioassay to measure estrogen levels in women with breast cancer receiving the aromatase inhibitor, letrozole. (1995) (51)
- Marijuana: interaction with the estrogen receptor. (1983) (50)
- Congenital adrenal hyperplasia due to 21-hydroxylase deficiency. (1990) (50)
- Somatomedin-C in accelerated growth of children with precocious puberty. (1985) (49)
- Growth hormone secretory dynamics in children with precocious puberty. (1987) (49)
- Role of surgery in management of adrenocorticotropic hormone-producing islet cell tumors of the pancreas. (1995) (49)
- Evaluation and management of precocious puberty. (1996) (49)
- Sensitivity of cortisol and adrenal androgens to dexamethasone suppression in hirsute women. (1985) (49)
- Ovarian Function in Girls with McCune-Albright Syndrome (1986) (48)
- Use of an ultrasensitive recombinant cell bioassay to determine estrogen levels in girls with precocious puberty treated with a luteinizing hormone-releasing hormone agonist. (1998) (48)
- Cyclical ovarian function resistant to treatment with an analogue of luteinizing hormone releasing hormone in McCune-Albright syndrome. (1984) (47)
- Variable response to a long-acting agonist of luteinizing hormone-releasing hormone in girls with McCune-Albright syndrome. (1984) (47)
- Heterogeneity of activating mutations of the human luteinizing hormone receptor in male-limited precocious puberty. (1996) (47)
- Effect of growth hormone dose on bone maturation and puberty in children with idiopathic short stature. (2006) (46)
- Effects of low-dose estrogen replacement during childhood on pubertal development and gonadotropin concentrations in patients with Turner syndrome: results of a randomized, double-blind, placebo-controlled clinical trial. (2014) (46)
- Pubertal growth: physiology and pathophysiology. (1986) (45)
- Inhaled growth hormone (GH) compared with subcutaneous GH in children with GH deficiency: pharmacokinetics, pharmacodynamics, and safety. (2009) (45)
- Primary Pigmented Nodular Adrenocortical Disease: A Light and Electron Microscopic Study of Eight Cases (1989) (45)
- Primary bilateral adrenocortical causes of Cushing's syndrome. (1991) (44)
- A seminiferous tubular factor is not obligatory for regulation of plasma follicle-stimulating hormone in the rat. (1981) (44)
- Dissociation of cortisol and adrenal androgen secretion in the hypophysectomized, adrenocorticotropin-replaced chimpanzee. (1984) (42)
- Therapeutic Applications of Luteinizing-Hormone-Releasing Hormone and Its Analogs (1985) (42)
- Pubertal endocrinology of the baboon: adrenarche. (1981) (42)
- Precocious puberty associated with neurofibromatosis and optic gliomas. Treatment with luteinizing hormone releasing hormone analogue. (1985) (42)
- Developmental changes in rabbit and dog adrenal function: a possible homologue of adrenarche in the dog. (1981) (42)
- Molecular basis of nonclassical steroid 21-hydroxylase deficiency detected by neonatal mass screening in Japan. (1997) (41)
- Recurrent Anaphylaxis in Menstruating Women: Treatment With a Luteinizing Hormone‐Releasing Hormone Agonist—A Preliminary Report (1987) (41)
- Identification of a major recombination hotspot in patients with short stature and SHOX deficiency. (2005) (41)
- Late-onset 21-hydroxylase deficiency is an allelic variant of congenital adrenal hyperplasia characterized by attenuated clinical expression and different HLA haplotype associations. (1982) (40)
- Luteinizing Hormone Releasing Hormone Analogue Therapy for Central Precocious Puberty: Long-term Effect on Somatic Growth, Bone Maturation, and Predicted Height (1986) (40)
- The effect of pubertal delay on adult height in men with isolated hypogonadotropic hypogonadism. (1992) (39)
- Analysis of gonadotropin-releasing hormone gene structure in families with familial central precocious puberty and idiopathic hypogonadotropic hypogonadism. (1990) (39)
- New approaches to the treatment of congenital adrenal hyperplasia. (1997) (39)
- Ovine corticotropin-releasing hormone stimulation test in normal children. (1986) (38)
- Metabolic clearance rate and plasma half-life of radioiodinated corticotropin releasing factor in a primate. (1982) (37)
- Acute effects of bromocriptine, cyproheptadine, and valproic acid on plasma adrenocorticotropin secretion in Nelson's syndrome. (1997) (37)
- Primary Adrenal Causes of Cushing's Syndrome; Diagnosis and Surgical Management (1989) (36)
- Rat adrenal androgen receptor: a possible mediator of androgen-induced decreased in rat adrenal weight. (1978) (36)
- Long‐Term Parathyroid Hormone 1‐34 Replacement Therapy in Children with Hypoparathyroidism (2018) (35)
- Unilateral testicular enlargement resulting from inapparent 21-hydroxylase deficiency. (1981) (35)
- 11-Deoxycortisol: a glucocorticoid antagonist in vivo. (1979) (33)
- Lack of efficacy of fadrozole in treating precocious puberty in girls with the McCune-Albright syndrome. (2003) (33)
- Progesterone Sensitivity as a Cause of Recurrent Anaphylaxis (1984) (32)
- Nodular Leydig cell hyperplasia in a boy with familial male-limited precocious puberty. (2001) (32)
- Boys with precocious puberty due to hypothalamic hamartoma: reproductive axis after discontinuation of gonadotropin-releasing hormone analog therapy. (2000) (32)
- Corticotropin-secreting carcinoid tumors of the thymus: diagnostic unreliability of thymic venous sampling. (1992) (32)
- Active clearance of corticotropin-releasing factor from the cerebrospinal fluid. (1985) (32)
- In boys with abnormal developmental tempo, maturation of the skeleton and the hypothalamic-pituitary-gonadal axis remains synchronous. (2004) (31)
- Rebound thymic hyperplasia after treatment of Cushing's syndrome. (1986) (31)
- Dissociation between cortisol and adrenal androgen secretion in patients receiving alternate day prednisone therapy. (1987) (30)
- A comparison of two methods for detecting hormone peaks: the effect of sampling interval on gonadotropin peak frequency. (1984) (30)
- Effects and pharmacokinetic properties of the rat/human corticotropin-releasing factor in rhesus monkeys. (1985) (30)
- Effect of deslorelin-induced pubertal delay on the growth of adolescents with short stature and normally timed puberty: preliminary results. (1993) (29)
- Effects of luteinizing hormone-releasing hormone analog-induced pubertal delay in growth hormone (GH)-deficient children treated with GH: preliminary results. (1997) (29)
- Effect of growth hormone treatment on testicular function, puberty, and adrenarche in boys with non-growth hormone-deficient short stature: a randomized, double-blind, placebo-controlled trial. (2001) (29)
- Effect of hydrocortisone dose schedule on adrenal steroid secretion in congenital adrenal hyperplasia. (1985) (29)
- Surgical strategy in the management of non-small cell ectopic adrenocorticotropic hormone syndrome. (1992) (29)
- Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with idiopathic isolated GH deficiency. (2014) (28)
- Thyroid abnormalities in children infected with human immunodeficiency virus. (1996) (28)
- Stimulation of gonadotropin secretion in prepubertal monkeys after hypothalamic excitation with aspartate and glutamate. (1990) (28)
- Rapid regression of fetal adrenal zone and absence of adrenal reticular zone in the marmoset. (1982) (27)
- Etiology of the differences in corticotropin-releasing hormone-induced adrenocorticotropin secretion of black and white women. (1996) (26)
- Adrenal function in women with idiopathic acne. (1982) (26)
- Pituitary and ovarian abnormalities demonstrated by CT and ultrasound in children with features of the McCune-Albright syndrome. (1984) (26)
- Isosexual precocious pseudopuberty secondary to a feminizing adrenal tumor. (1984) (26)
- Ultrasound evaluation of female isosexual precocious puberty. (1984) (25)
- Progesterone sensitivity as a cause of recurrent anaphylaxis. (1985) (25)
- Combining insulin-like growth factor-I and mean spontaneous nighttime growth hormone levels for the diagnosis of growth hormone deficiency. (1992) (25)
- The effect of short term treatment with growth hormone and ethinyl estradiol on lower leg growth rate in girls with Turner's syndrome. (1988) (25)
- Effects of treatment with oxandrolone for 4 years on the frequency of severe arithmetic learning disability in girls with Turner syndrome. (2009) (24)
- The Effect of Serum Prolactin on Plasma Adrenal Androgens and the Production and Metabolic Clearance Rate of Dehydroepiandrosterone Sulfate in Normal and Hyperprolactinemic Subjects (1986) (24)
- Caloric balance, brain to body ratio, and the timing of menarche. (1984) (24)
- Leydig cell hypoplasia causing male pseudohermaphroditism: diagnosis 13 years after prepubertal castration. (1984) (23)
- Long-Term Testolactone Therapy for Precocious Puberty in Girls With the McCune-Albright Syndrome (1994) (23)
- Corticotropin-releasing hormone (CRH) stimulation in Nelson's syndrome: response of adrenocorticotropin secretion to pulse injection and continuous infusion of CRH. (1986) (23)
- Corticotropin releasing factor: basic and clinical studies. (1983) (23)
- Sexual Precocity: Etiology, Diagnosis, and Management (1993) (22)
- Growth response relationship between growth hormone dose and short term growth in patients with Turner's syndrome. (1986) (22)
- Corticotropin releasing factor: Basic studies and clinical applications (1985) (22)
- Replacement oral ethinyloestradiol therapy for gonadal dysgenesis: growth and adrenal androgen studies (1979) (22)
- Dental Development in Precocious Puberty (1985) (22)
- Development of glucocorticoid antagonists. (1983) (22)
- A novel testis-stimulating factor in familial male precocious puberty. (1991) (22)
- Mutations of the CYP21 gene in nonclassical steroid 21-hydroxylase deficiency in Japan. (1998) (21)
- Variability in Hormone Concentrations and Self-Reported Menstrual Histories in Young Adolescents: Menarche as an Integral Part of a Developmental Process (1999) (20)
- Screening a large pediatric cohort with GH deficiency for mutations in genes regulating pituitary development and GH secretion: Frequencies, phenotypes and growth outcomes (2018) (19)
- Effect of carbenoxolone on the plasma renin activity and hypothalamic–pituitary–adrenal axis in congenital adrenal hyperplasia due to 21‐hydroxylase deficiency* (1999) (19)
- Luteinizing hormone-releasing hormone (LHRH)-independent precocious puberty unresponsive to LHRH agonist therapy in two girls lacking features of the McCune-Albright syndrome. (1991) (19)
- Overnight growth hormone concentrations are usually normal in pubertal children with idiopathic short stature--a Clinical Research Center study. (1996) (18)
- Testolactone treatment of precocious puberty in McCune-Albright syndrome. (1985) (18)
- Luteinizing hormone releasing hormone analogue therapy for central precocious puberty. Long-term effect on somatic growth, bone maturation, and predicted height. (1986) (18)
- Differences in the hypothalamic-pituitary-adrenal axis of black girls and white girls. (1996) (17)
- Δ1,9(11))-ll-Deoxy cortisol: An Improved Glucocorticoid Antagonist (1980) (16)
- In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog (2016) (16)
- Role of preoperative iodocholesterol scintiscanning in patients undergoing adrenalectomy for Cushing's syndrome. (1995) (16)
- The effect of pulsatile human corticotropin-releasing hormone administration on the adrenal insufficiency that follows cure of Cushing's disease. (1989) (16)
- Thermal stability of a long-acting analogue of luteinizing hormone releasing hormone (D-trp6-pro9-NEt-LHRH). (1983) (16)
- Biobehavioral aspects of precocious puberty. (1986) (16)
- Neurocognitive function and brain imaging in Turner syndrome--preliminary results. (1993) (15)
- Dose-response relationship between thyroid hormone and growth velocity in cynomolgus monkeys. (1988) (15)
- Pituitary Tumor Hemorrhage in Cushing Disease (1995) (15)
- Adrenal steroid responses to continuous intravenous adrenocorticotropin infusion compared to bolus injection in normal volunteers. (1986) (15)
- LHRH Analog Treatment of Central Precocious Puberty Complicating Congenital Adrenal Hyperplasia (1985) (15)
- Central precocious puberty complicating a virilizing adrenal tumor: treatment with a long-acting LHRH analog. (1985) (14)
- Failure of bronchial lavage to detect elevated levels of adrenocorticotropin (ACTH) in patients with ACTH-producing bronchial carcinoids. (1989) (14)
- Inferior petrosal sinus arginine vasopressin concentrations in normal volunteers and patients with Cushing's disease. (1996) (14)
- Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin‐releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty (2017) (14)
- Androgen receptor characteristics in skin fibroblasts from hirsute women. (1985) (13)
- Recovery of reproductive function in rats treated with the aromatase inhibitor fadrozole. (1996) (13)
- Effect of deslorelin dose in the treatment of central precocious puberty. (1991) (13)
- SC 25152: A potent mineralocorticoid antagonist with reduced affinity for the 5 alpha-dihydrotestosterone receptor of human and rat prostate. (1978) (13)
- Radioimmunoassay for chicken calcitonin (1974) (12)
- MR imaging of a large adrenal cyst. (1986) (12)
- Familial male precocious puberty. (2020) (12)
- Inferior petrosal sinus AVP in patients with Cushing's syndrome (1997) (12)
- Effect of growth hormone secretagogue LY444711 on IGF‐1, growth hormone, and cortisol levels in beagle dogs after one and seven daily oral doses (2000) (12)
- Pitfalls in the Use of Inferior Petrosal Sinus Sampling for the Differential Diagnosis of Acth-dependent Cushing's Syndrome (1994) (12)
- Effect of Hydrocortisone Dose Schedule on Adrenal Steroid Secretion in Congenital Adrenal Hyperplasia (1985) (11)
- Growth hormone insensitivity syndrome due to point deletion and frame shift in the growth hormone receptor. (1995) (11)
- LINEAR GROWTH IN THE RABBIT IS CONTINUOUS, NOT SALTATORY (1993) (11)
- Cortisol response to individualised graded insulin infusions: a reproducible biomarker for CNS compounds inhibiting HPA activation. (2010) (11)
- Biosynthesis and secretion of calcitonin by avian ultimobranchial glands. (1977) (11)
- Development of additional pituitary hormone deficiencies in pediatric patients originally diagnosed with isolated growth hormone deficiency due to organic causes. (2016) (11)
- Ultrasonography of Turner's syndrome. (1986) (11)
- Δ1-11-oxa-11-deoxycortisol: A new antiglucocorticoid with activity in vivo (1982) (10)
- Linear growth in the rabbit is continuous, not saltatory. (1994) (10)
- Prenatal diagnosis of steroid 21-hydroxylase deficiency by the modified polymerase chain reaction to detect splice site mutation in the CYP21 gene. (1998) (9)
- Glucocorticoid receptor-mediated effects on rat fibrosarcoma growth. (1988) (9)
- The corticotropin releasing factor stimulation test in the evaluation of patients with adrenal insufficiency (1984) (9)
- Identification of ACTH-producing intrathoracic tumors by measuring ACTH levels in aspirated specimens. (1987) (9)
- Corticotropin-releasing factor stimulation test. (2010) (8)
- Therapy with PTH 1-34 or Calcitriol and Calcium in Diverse Etiologies of Hypoparathyroidism over 27 Years at a Single Tertiary Care Center. (2021) (8)
- Short-term safety of somatropin inhalation powder in adults with mild to moderate asthma. (2009) (8)
- Late-onset 21-hydroxylase deficiency. (1982) (8)
- Potential limitations of recrystallization for the definitive identification of radioactive steroids (1980) (8)
- SC 25152: a potent mineralocorticoid antagonist with decreased antiandrogenic activity relative to spironolactone. (1979) (8)
- Phe576 plays an important role in the secondary structure and intracellular signaling of the human luteinizing hormone/chorionic gonadotropin receptor. (1997) (8)
- Evidence that synthetic 31-amino acid inhibin-like peptide lacks inhibin activity. (1985) (7)
- Characterization, Expression, and Estradiol Regulation of the Human GnRH Gene (1992) (7)
- Follow-up of children and young adults after GnRH-agonist therapy for central precocious puberty (2001) (7)
- Pegyled insulin-lispro compounds (2009) (7)
- Replacement oral ethinyloestradiol therapy for gonadal dysgenesis: growth and adrenal androgen studies. (1980) (7)
- Pulsatile human corticotropin-releasing hormone prevents dexamethasone-induced suppression of the plasma cortisol response to hypoglycemia in normal men. (1992) (7)
- Blood Pressure and Body Size in Precocious Puberty (1988) (7)
- LHRH analog therapy of precocious puberty (1984) (6)
- Report from the International Society of Endocrinology (1985) (6)
- Does availability of AIR insulin increase insulin use and improve glycemic control in patients with type 2 diabetes? (2009) (6)
- NIH conference. Therapeutic applications of luteinizing-hormone-releasing hormone and its analogs. (1985) (5)
- Localization by venous sampling of occult chorionic gonadotropin-secreting tumor in a boy with mosaic Klinefelter's syndrome and precocious puberty. (1996) (5)
- 487 THE EFFECT OF LOW DOSE ESTRADIOL ON 6 MONTH GROWTH RATES IN PATIENTS WITH TURNER'S SYNDROME (1985) (5)
- Effect of gonadotropin secretion rate on the radiosensitivity of the rat luteinizing hormone-releasing hormone neuron and gonadotroph. (1988) (5)
- Repeated, childhood vaginal bleeding is not always precocious puberty. (1992) (4)
- Idiopathic Precocious Puberty in the Chimpanzee: A Case Report (1984) (4)
- Gonadal and Adrenal Hormone Correlates of Adjustment in Early Adolescence (2021) (4)
- Carbenoxolone effects in congenital adrenal hyperplasia (2000) (4)
- Comparative immunochemical studies of chicken ultimobranchial calcitonin. (1974) (4)
- Effects of the luteinizing hormone-releasing hormone (LHRH) analog D-Trp6-Pro9-NEt-LHRH on the pituitary-gonadal axis of prepubertal rhesus monkeys. (1984) (4)
- Growth Hormone Plus Childhood Low-Dose Estrogen in Turner Syndrome (2011) (4)
- Scleral Calcifications in Hyperparathyroidism: Demonstration by Computed Tomography (1977) (4)
- Scleral calcifications in hyperparathyroidism: demonstration by computed tomography. (1977) (4)
- Mechanism of precocious puberty in McCune-Albright syndrome (MAS) (1981) (4)
- High DHEAS in girls and metabolic features throughout pubertal maturation (2021) (3)
- Urodynamic abnormalities in two brothers with adrenomyeloneuropathy (2005) (3)
- DESLORELIN-INDUCED DELAY OF PUBERTY INCREASES ADULT HEIGHT OF ADOLESCENTS WITH SHORT STATURE: RESULTS OF A RANDOMIZED, PLACEBO-CONTROLLED TRIAL.▴ 592 (1996) (3)
- Estrogen Therapy in Turner's Syndrome (1992) (3)
- Pituitary Desensitization with a Long-Acting Luteinizing-Hormone-Releasing Hormone Analog (1983) (3)
- Chapter 6 Molecular aspects of precocious puberty (1998) (3)
- Corticotropin-releasing hormone in the hypercortisolism of depression and Cushing's disease. (1987) (2)
- Therapy of precocious puberty: LHRH analogue effects on pubertal growth and maturation (1984) (2)
- Ovarian steroidogenic enzyme activities during the rat estrous cycle (1982) (2)
- 110 CURRENT MANAGEMENT OF CONGENITAL ADRENAL HYPERPLASIA (CAH): A SURVEY OF THE LAWS0N WILKINS PEDIATRIC ENDOCRINE SOCIETY (LWPES) (1985) (2)
- The NIH Experience With Precocious Puberty: Diagnostic Subgroups and Response to Short-Term Luteinizing Hormone Releasing Hormone Analogue Therapy (1986) (2)
- 21-Hydroxylase Deficiency: Overview of Treatment (1992) (2)
- Stimulated as compared with spontaneous growth hormone levels for diagnosis of growth hormone deficiency. (1988) (2)
- Treatment of Hypoparathyroidism with Parathyroid Hormone 1–34 (2015) (2)
- Spontaneous vulvar necrotizing fasciitis in Cushing's syndrome. (1994) (2)
- Pro-opiomelanocortin and Regulation of Adrenal Androgen (1987) (2)
- DIFFERENCES IN THE HYPOTHALAMIC-PITUITARY-ADRENAL (HPA) AXIS OF BLACK AND WHITE GIRLS. † 591 (1996) (1)
- SOMATOMEDIN C IN PRECOCIOUS PUBERTY (1984) (1)
- 476 LOW DOSE ESTRADIOL ACCELERATES ULNAR GROWTH IN BOYS (1985) (1)
- Metablism, Endocrinology and ImmunologyDissociation of Cortisol and Adrenal Androgen Secretion in the Hypophysectomized, Adrenocorticotropin-Replaced Chimpanzee (1985) (1)
- Potential therapeutic use of a long-acting LHRH analog in idiopathic true precocious puberty (IPP) (1980) (1)
- Sex differences in dental development in children with precocious puberty related to central nervous system lesions. (1986) (1)
- A preliminary study of the effect of estrogen dose on growth in turner’s syndrome (1984) (1)
- PITUITARY APIASIA IN AN 11 YEAR OLD GIRL: BIOCHEMICAL AND RADIOLOGICAL EVALUATION (1984) (1)
- Genome-Wide Association Study And Polygenic Risk Scores Of Serum Dheas Levels In A Chilean Children Cohort. (2021) (1)
- Effect of thyroid hormone on epidermal growth factor-like immunoreactivity and growth velocity in cynomolgus monkeys. (1990) (1)
- Corticotropin-Releasing Hormone (CRH): Clinical Studies and Use (1997) (1)
- THE ADRENAL SUPPRESSIVE EFFECT OF HYDROCORTISONE IN CONGENITAL ADRENAL HYPERPLASIA (CAH) IS NOT AFFECTED BY VARYING THE DOSE SCHEDULE (1984) (1)
- THYROID FUNCTION IN NON-GH-DEFICIENT SHORT CHILDREN DURING A PLACEBO-CONTROLLED DOUBLE-BLIND TRIAL OF GH THERAPY (1993) (1)
- Treatment of hypopituitary children. (2004) (1)
- IGF-I Treatment Increases Growth Velocity in Children with Non-Growth Hormone-Deficient Short Stature • 451 (1998) (1)
- Pathogenesis and therapy of precocious puberty (1992) (1)
- The Optimal Use of Estrogen in the Treatment of Turnerʼs Syndrome (1992) (0)
- MECHANISM OF PRECOCIOUS PUBERTY IN GIRLS WITH McCUNE-ALBRIGHT SYNDROME (MAS) (1984) (0)
- Premature Adolescence: Neuroendocrine and Psychosocial Studies (2021) (0)
- Trial with Idiopathic Short Stature: A Randomized, Double-Blind, Placebo-Controlled Effect of Growth Hormone Treatment on Adult Height in Peripubertal Children (2004) (0)
- Pubertal Changes in Bone Mineral Content of The Wrist and Spine in Normal Boys and Girls (1994) (0)
- CATCH-UP GROWTH IS INTRINSIC TO THE EPIPHYSEAL GROWTH PLATE (1993) (0)
- in Pediatric Patients Originally Diagnosed with Idiopathic (2013) (0)
- Modern approach to corticosteroid replacement therapy (1996) (0)
- 79. LHRH analog therapy in boys with true precocious puberty due to hypothalamic hamartoma (1982) (0)
- COMPOUND HETEROZYGOUS MUTATIONS OF THE LUTEINIZING HORMONE/CHORIONIC GONADOTROPIN RECEPTOR GENE IN A FAMILY WITH TWO CHILDREN AFFECTED BY LEYDIG CELL HYPOPLASIA (LCH). • 387 (1997) (0)
- Differential methylation pattern in pubertal girls associated with biochemical premature adrenarche. (2023) (0)
- Activity of adrenal enzymes in a child with Cushing's syndrome and micronodular adrenal disease (1989) (0)
- LONG-TERM TREATMENT OF FAMILIAL MALE PRECOCIOUS PUBERTY (FMPP) WITH SPIRONOLACTONE, TESTOLACTONE, AND DESLORELIN. † 536 (1996) (0)
- LONG-TERM EFFECTS OF GROWTH HORMONE, ESTROGEN, OR PLACEBO ON SELF-IMAGE AND BEHAVIOR IN TURNER SYNDROME (1993) (0)
- Resolution of Abnormal Gonadotropin Secretion After Surgical Cure in Men With ACTH-Dependent Cushing Syndrome (2021) (0)
- ULTRASOUND INVESTIGATION OF TURNER'S SYNDROME. (1984) (0)
- In Vivo and In Vitro Characterization of Basal Insulin Peglispro: A Novel Insulin Analog s (2016) (0)
- Delta 1,9(11)-11-deoxycortisol: an improved glucocorticoid antagonist. (1980) (0)
- Annotations Evaluation and management of precocious puberty (2006) (0)
- Chapter 9 - The Adrenal Cortex (1997) (0)
- List of Contributors and Discussants (1981) (0)
- TREATMENT OF A BOY WITH GROWTH HORMONE INSENSITIVITY SYNDROME WITH rhIGF-I AND LHRH ANALOG (1993) (0)
- Effects of Lhrh-Analog (Lhrh-A)-Induced Pubertal Delay in Growth Hormone Deficient Children Treated With Growth Hormone: Preliminary Results of A Randomized, Placebo-Controlled Trial. 1 (1998) (0)
- APPROPRIATE BONE DENSITY FOR HEIGHT IN ESTROGEN-TREATED ADOLESCENT GIRLS WITH TURNER SYNDROME. † 570 (1996) (0)
- Forthcoming papers (1985) (0)
- Late onset 21-hydroxylase deficiency is a genetic variant of the classic form of congenital adrenal hyperplasia (CAH) (1981) (0)
- THE CUSHING SYNDROME. AUTHOR REPLY (1995) (0)
- 193 CATECHOLAMINE EXCRETION IN PRECOCIOUS PUBERTY (1985) (0)
- 21 TIMING OF ADRENARCHE AMD GONADARCHE AND PSYCHOLOGICAL ADJUSTMENT NORMAL ADOLESCENTS (1985) (0)
- Familial male precocious puberty. (1994) (0)
- Contents, Vol. 34, 1990 (1990) (0)
- Mutations of the 21-Hydroxylase CYP 21 Gene Deficiency in in Nonclassical Steroid Japan (2006) (0)
- Subject Index, Vol. 34, 1990 (1990) (0)
- Ca2+-SENSING RECEPTOR MUTATIONS IN SPORADIC HYPOPARATHYROIDISM.• 507 (1996) (0)
- LHRH SECRETION OF IMMORTALIZED HYPOTHALAMIC NEURONS IS STIMULATED BY N-ACETYLASPARTYLGLUTAMATE (1993) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Gordon B. Jr. Cutler?
Gordon B. Jr. Cutler is affiliated with the following schools:
